Ketorolac Tromethamine Injection — FDA Drug Shortage

No longer listed by FDA — Gland Pharma Limited

The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Gland Pharma Limited with status No longer listed by FDA. The shortage was first posted on Mar 23, 2018. Reported reason: Demand increase for the drug

Shortage details

Status
No longer listed by FDA
Company
Gland Pharma Limited
Package NDC
70860-701-04
Dosage Form
Injection
Presentation
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-04)
Initial Posting
Mar 23, 2018

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.